Bevacizumab and daily temozolomide for recurrent glioblastoma
Year: 2011
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.26381
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2047138539